Presentations

Please use the menu on the right to browse presentations by year, cancer type or author, or enter a search term in the box below.

It should be noted that the results contained in some of the abstracts and related content are preliminary and subject to change.

Displaying 1 - 6 of 6 presentations
Click here to reset all search parameters [1]

Effect of pre-diagnostic NSAID use on ovarian cancer survival [2]

Brown C, Barron T I, Bennett K, Sharp L.
National Cancer Research Institute (NCRI) Cancer Conference 2015 . 6 Nov 2015, Liverpool, UK [Oral presentation]
. Nov 2015 () [published abstract]
Role of tumour histology in beta blocker association with ovarian cancer survival [3]

Brown C, Barron T I, Bennett K, Sharp L.
2nd Ovarian Cancer Forum of Ireland. 9 Oct 2015 to 10 Oct 2015, Enniskillen, Co Fermanagh [Poster presentation]
Effect of drug class on association of beta-blocker with ovarian cancer survival [4]

Brown C, Barron T I, Bennett K, Sharp L.
2nd Irish Association of Pharmacologists Conference. 16 Oct 2015, UCC, Cork [Oral presentation]
Associations between pre- and post-diagnostic use of beta-blockers and ovarian cancer survival [5]

Brown C, Barron T I, Bennett K, Sharp L.
21st National Cancer Intelligence Network (NCIN) Cancer Outcomes Conference 2015. 8 Jun 2015 to 10 Jun 2015, Europa Hotel, Belfast, United Kingom [Oral presentation]
Eur J Cancer Care. Jun 2015 24 (S1) 1-23 [published abstract]
A meta-analytic approach to large scale competing risks regression [6]

Brown C.
35th Conference on Applied Statistics in Ireland. 11 May 2015 to 13 May 2015, Cork, Ireland [Oral presentation]
Do ovarian cancer patients using statins have better outcomes? [7]

Brown C, Barron T I, Bennett K, Sharp L.
All Ireland Cancer Consortium Conference 2015. 11 May 2015 to 13 May 2015, Riddel Hall, Queen's University Belfast [Poster presentation]

[8]

[9]